Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
What will members gain?

Download Now: New Slide Deck Programme

Previous slide decks focused on landmark studies which used a monoclonal antibody approach to inhibit PCSK9. The next in this series discusses inclisiran, a small interfering RNA therapy, which prevents production of PCSK9 at its primary source in the liver.

Find out more »
Most viewed

Hot Topics

12th Closed Virtual Meeting of the Editorial Board of PCSK9 Forum

Do we need to reconsider LDL cholesterol targets in stroke patients?
 
With insights from the Treat Stroke to Target trial, FOURIER and ODYSSEY OUTCOMES, the question is: what should be the LDL cholesterol targets in stroke patients?
 

Professor Pierre Amarenco (Bichat Hospital, University of Paris, France) puts the data into perspective

Watch the webcast

 

Professor Wouter Jukema (Leiden University Medical Center, The Netherlands) discusses findings from ODYSSEY OUTCOMES

Watch the webcast

From the Editors

LDL cholesterol targets in stroke patients: where to?

Professor Pierre Amarenco, Bichat Hospital, University of Paris, France, makes the case for reconsideration of LDL cholesterol targets to prevent stroke, based on evidence from recent trials.

Read the report

 

Other related reports:
Treat ischaemic stroke to target
Watch the webcast
ODYSSEY OUTCOMES and stroke events
Watch the webcast
PCSK9 inhibition: impact on stroke
Read the report
How low should LDL cholesterol be lowered after stroke?
Read the report

ACC 2017

Meet our Editorial Board

View all our Editorial Board Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research Dr Michel FarnierClinician based at Point Medical, Dijon, France Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology